Enovis
ENOVEnovis Corporation is a medical technology company that develops and manufactures clinically differentiated solutions for reconstructive surgery, rehabilitation, and physical therapy.
Earnings
Next report
Aug 6, 2026 (In 3 weeks)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Enovis Corporation is a medical technology company that develops and manufactures clinically differentiated solutions for reconstructive surgery, rehabilitation, and physical therapy. The company provides a broad range of medical devices and services designed to improve patient outcomes and transform clinical workflows across the continuum of care, from injury prevention to post-surgical recovery. Its core value proposition is centered on enabling patients to regain or maintain natural motion through high-quality surgical implants and non-surgical orthopedic products.
Enovis positions itself as a leading medical technology partner leveraging its proprietary EGX business system to drive continuous improvement and innovation in fragmented orthopedic markets.
Questions, answered.
- What is Enovis's market cap?
- Enovis (ENOV) has a market capitalization of $1.4B and trades on NYSE.
- What is Enovis's revenue and profitability?
- Enovis generated $2.3B in trailing twelve-month revenue with a net loss of $1.1B, representing a net margin of -49.9%. Gross margin stands at 60.5%, with free cash flow of -$73.1M. These figures are based on the Q1 2026 filing.
- Who are Enovis's competitors?
- Enovis's key competitors include Zimmer Biomet, DePuy Synthes, Stryker, and others. These companies compete in similar markets and product categories.
- Who does Enovis partner with?
- Enovis's notable partners include Medicare, Medicaid.
- What subsidiaries does Enovis have?
- Enovis's subsidiaries include Lima Corporate, ESAB Corporation.
- Where is Enovis headquartered?
- Enovis is headquartered in United States of America and employs approximately 6,550 people. It has been publicly traded since 2008.
